Article
Association between polymorphisms of microsomal epoxide hydrolase and COPD: results from meta-analyses.
Guangzhou Institute of Respiratory Diseases, State Key Lab of Respiratory Disease, The First Affiliated Hospital, Guangzhou Medical College, Guangzhou, Guangdong, China.
Respirology (impact factor:
2.42).
12/2008;
13(6):837-50.
DOI:10.1111/j.1440-1843.2008.01356.x
pp.837-50
Source: PubMed
-
Citations (0)
- Cited In (1)
-
Article: Chronic obstructive pulmonary disease: towards pharmacogenetics.
[show abstract] [hide abstract]
ABSTRACT: Chronic obstructive pulmonary disease (COPD) is a common problem worldwide, and it is recognized that the term encompasses overlapping sub-phenotypes of disease. The development of a sub-phenotype may be determined in part by an individual's genetics, which in turn may determine response to treatment. A growing understanding of the genetic factors that predispose to COPD and its sub-phenotypes and the pathophysiology of the condition is now leading to the suggestion of individualized therapy based on the patients' clinical phenotype and genotype. Pharmacogenetics is the study of variations in treatment response according to genotype and is perhaps the next direction for genetic research in COPD. Here, we consider how knowledge of the pathophysiology and genetic risk factors for COPD may inform future management strategies for affected individuals.Genome Medicine 11/2009; 1(11):112.
Data provided are for informational purposes only. Although carefully collected, accuracy cannot be guaranteed.
The impact factor represents a rough estimation of the journal's impact factor and does not reflect the actual
current impact factor.
Publisher conditions are provided by RoMEO. Differing provisions from the publisher's actual policy or licence
agreement may be applicable.
Keywords
Asian population
candidate loci
case-control studies
Caucasian population
clearer understanding
complex polygenic disease
COPD susceptibility
eligible studies
EPHX1 139 heterozygote
gene types
gene-environment interactions
histidine/arginine 139
inconsistent results
larger-sample-size studies
pooled results
published data
putative EPHX1 phenotypes
slow activity phenotype
systematic review
tyrosine/histidine 113